Skip to main content

Peltz Stuart Walter's Form 4 filing

PTC Therapeutics, Inc. (PTCT) · filed Jan 11, 2022

Accession no.
0001179110-22-000394
Filed
Jan 11, 2022
Trade date
Jan 7, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $83.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Peltz Stuart WalterCIK 0001578962Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 7, 2022Common StockSSaleDisposed−1,869$38.53−$72,012.5778,446Direct
Jan 7, 2022Common StockAGrant or awardAcquired+44,000$0.00$0122,446Direct
Jan 7, 2022Common StockSSaleDisposed−294$38.53−$11,327.8222,540Indirect
Jan 7, 2022Common StockAGrant or awardAcquired+16,800$0.00$039,340Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 7, 2022Common StockAGrant or awardAcquired+165,000$0.00$0165,000Direct
Jan 7, 2022Common StockAGrant or awardAcquired+63,000$0.00$063,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)